Skip to main content

Nephrology Articles tagged as Visual Abstract

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy (RENAAL)

N Engl J Med. 2001 Sep 20;345(12):861-9
Diabetic Kidney Disease
Randomized Trial SHSC Visual Abstract

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinman B; EMPA-REG OUTCOME Investigators
N Engl J Med. 2016 Jul 28;375(4):323-34. doi: 10.1056/NEJMoa1515920
Diabetic Kidney Disease General Nephrology
Visual Abstract

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; TREAT Investigators
N Engl J Med. 2009 Nov 19;361(21):2019-32
Anemia
Randomized Trial Visual Abstract

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Edmund J. Lewis, M.D., Lawrence G. Hunsicker, M.D., William R. Clarke, Ph.D., Tomas Berl, M.D., Marc A. Pohl, M.D., Julia B. Lewis, M.D., Eberhard Ritz, M.D., Robert C. Atkins, M.D., Richard Rohde, B.S., and Itamar Raz, M.D., for the Collaborative Study G
N Engl J Med. 2001 Sep 20;345(12):851-60
Diabetic Kidney Disease
Randomized Trial SHSC Visual Abstract
ukidneyisup